These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16640955)

  • 1. Nonconventional genetic risk factors for cardiovascular disease.
    Tymchuk CN; Hartiala J; Patel PI; Mehrabian M; Allayee H
    Curr Atheroscler Rep; 2006 May; 8(3):184-92. PubMed ID: 16640955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible genetic predisposition to cardiac effects.
    Manev H; Manev RM
    Med J Aust; 2005 Feb; 182(4):198; author reply 199. PubMed ID: 15720180
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic determinants of 5-lipoxygenase pathway in a Spanish population and their relationship with cardiovascular risk.
    Camacho M; Martinez-Perez A; Buil A; Siguero L; Alcolea S; López S; Fontcuberta J; Souto JC; Vila L; Soria JM
    Atherosclerosis; 2012 Sep; 224(1):129-35. PubMed ID: 22835628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.
    Rosoff DB; Davey Smith G; Mehta N; Clarke TK; Lohoff FW
    PLoS Med; 2020 Dec; 17(12):e1003410. PubMed ID: 33275596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared Genetic Contribution of Type 2 Diabetes and Cardiovascular Disease: Implications for Prognosis and Treatment.
    Strawbridge RJ; van Zuydam NR
    Curr Diab Rep; 2018 Jun; 18(8):59. PubMed ID: 29938349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-Environment Interactions for Cardiovascular Disease.
    Hartiala JA; Hilser JR; Biswas S; Lusis AJ; Allayee H
    Curr Atheroscler Rep; 2021 Oct; 23(12):75. PubMed ID: 34648097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do genetic variations alter the effects of exercise training on cardiovascular disease and can we identify the candidate variants now or in the future?
    Hagberg JM
    J Appl Physiol (1985); 2011 Sep; 111(3):916-28. PubMed ID: 21565989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding cardiovascular disease through the lens of genome-wide association studies.
    Arking DE; Chakravarti A
    Trends Genet; 2009 Sep; 25(9):387-94. PubMed ID: 19716196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
    Vrablik M; Dlouha D; Todorovova V; Stefler D; Hubacek JA
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of CVD in 2017: Expanding the spectrum of CVD genetics.
    Schunkert H
    Nat Rev Cardiol; 2018 Feb; 15(2):77-78. PubMed ID: 29263443
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular disease: genes and public health.
    Harrap SB
    Ann Acad Med Singap; 2000 May; 29(3):279-83. PubMed ID: 10976379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-lipoxygenase/leukotriene pathway in preclinical models of cardiovascular disease.
    Poeckel D; Funk CD
    Cardiovasc Res; 2010 May; 86(2):243-53. PubMed ID: 20093252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease.
    El-Lebedy D; Raslan HM; Mohammed AM
    Cardiovasc Diabetol; 2016 Jan; 15():12. PubMed ID: 26800892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Whole Exome Sequencing in the Clinical Diagnosis and Management of Inherited Cardiovascular Diseases in Adults.
    Seidelmann SB; Smith E; Subrahmanyan L; Dykas D; Abou Ziki MD; Azari B; Hannah-Shmouni F; Jiang Y; Akar JG; Marieb M; Jacoby D; Bale AE; Lifton RP; Mani A
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28087566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.
    Krasi G; Precone V; Paolacci S; Stuppia L; Nodari S; Romeo F; Perrone M; Bushati V; Dautaj A; Bertelli M
    Acta Biomed; 2019 Sep; 90(10-S):7-19. PubMed ID: 31577248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association studies in cardiovascular diseases: Do we have enough power?
    Auer PL; Stitziel NO
    Trends Cardiovasc Med; 2017 Aug; 27(6):397-404. PubMed ID: 28456354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel genetic variants associated with cardiorespiratory fitness.
    Bye A; Klevjer M; Ryeng E; Silva GJJD; Moreira JBN; Stensvold D; Wisløff U
    Prog Cardiovasc Dis; 2020; 63(3):341-349. PubMed ID: 32035127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors in cardiovascular disease. 10 questions.
    Lusis AJ
    Trends Cardiovasc Med; 2003 Nov; 13(8):309-16. PubMed ID: 14596945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From candidate gene to genome-wide association studies in cardiovascular disease.
    Gianfagna F; Cugino D; Santimone I; Iacoviello L
    Thromb Res; 2012 Mar; 129(3):320-4. PubMed ID: 22154244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.